Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isotechnika Pharma Inc IPHAF



GREY:IPHAF - Post by User

Post by player121on Apr 27, 2010 3:53pm
564 Views
Post# 17036711

Take a look at the FS

Take a look at the FSDid you ever look at the financial statements?  For year end they stated that $191,000 was spent on external IR and public company costs.  I don't think she was "on her own" or "learning her craft" without guidance from professional firms or management for that matter.  Doesn't look like the "professionals" have done too much for managing the share price. 

Either way, from what I understand they haven't had anyone in an IR role in over a year...who is to blame for that?  Could they not find someone else to fill the role or do they even care about communicating to the shareholders or investment community???
<< Previous
Bullboard Posts
Next >>